NCT05370521 2025-10-09
A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal Androgens
Spruce Biosciences
Phase 2 Terminated
Clinical Trials
11 trialsNCT03951077 2022-06-08
Study of the Safety and Efficacy of Elagolix in Women With Polycystic Ovary Syndrome
AbbVie
Phase 2 Completed
NCT02865915 2021-02-01
MLE4901 vs. Placebo for the Treatment of PCOS
Millendo Therapeutics, Inc.
Phase 2 Terminated
NCT03152591 2021-01-05
PCOS
Novartis
Phase 2 Completed
NCT02328404 2016-08-04
The Effect of Vitamin D Supplementation Among Overweight Jordanian Women With Polycystic Ovary Syndrome (PCOS)
Hayat Pharmaceutical Co. PLC
Phase 3 Completed
NCT01653743 2016-01-07
Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT01872078 2015-10-12
A Study of AZD4901 in Females With Polycystic Ovary Syndrome
AstraZeneca
Phase 2 Completed
NCT01081626 2014-02-13
Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction
Merck KGaA, Darmstadt, Germany
Phase 4 Completed
NCT01185704 2014-02-13
ATTAC-PCO
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT01185782 2013-12-27
SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese Infertile Women
Merck KGaA, Darmstadt, Germany
Phase 3 Completed
NCT00805935 2012-01-27
Menopur® Versus Follistim® in Polycystic Ovarian Syndrome (PCOS)
Ferring Pharmaceuticals
Phase 4 Completed